Artri King Tablets Recalled Due to Undeclared Diclofenac
Artri King Reforzado con Ortiga Omega 3 Tablets are being recalled for containing undeclared diclofenac and being marketed without FDA approval. The recall affects 1,308 bottles distributed nationwide.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: FDA classified this as a Class I recall, which mandates a minimum severity score of 4. The product was marketed without required FDA approval and contains an undeclared active pharmaceutical ingredient.
Plain-English summary
Artri King Reforzado con Ortiga Omega 3 Tablets (100-count bottles) are being recalled nationwide. The affected product lot is LTARTKNGOMG30720, expiring December 2026. A total of 1,308 bottles have been distributed.
The product was found to contain undeclared diclofenac, a nonsteroidal anti-inflammatory drug (NSAID) approved by the FDA for treating pain and inflammation. The product was marketed without an FDA-approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA).
Consumers who have purchased this product should stop using it. Anyone who has taken the tablets and has concerns should consult a healthcare provider.
The recalled product
- Product
- Artri King Reforzado con Ortiga Omega 3 Tablets, ORIGINAL, 100-count bottles, Melchor Ocampo No. 55 Local D, Delegacion Xochimilco, C.P. 16800, Mexico, D.F., UPC 7 501031 111190.
- Manufacturer
- Walmart Inc
- Category
- Drug
- Hazard
- undeclared-ingredient
- unapproved-drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot: LTARTKNGOMG30720
- Exp Diciembre 2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- HighBeak & Skiff Alcohol Antiseptic Sanitizer recalled for acetaldehyde contamination
FDA (Drugs) · 2026-06-17
- SevereCIMZIA injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-05-27
- SevereAtomoxetine Capsules Recalled Due to Labeling Mix-Up Error
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27